Higher MCT4 expression in cancer tissues at more advanced stages and a clear correlation between higher MCT4 expression and poorer prognosis were also observed in patients with lung adenocarcinoma (Supplementary Fig. S8). Here, SLC16A3 is linked to lung adenocarcinoma.